AAO 2025: Inovations in glaucoma laser therapyBySheryl Stevenson,Sydney M Crago,Joel S. Schuman, MDOctober 22nd 2025
AAO 2025: The safety and efficacy of oral gildeuretinol in participants with intermediate-stage Stargardt diseaseByPhilip Ferrone, MD,Sheryl Stevenson,Sydney M CragoOctober 20th 2025
AAO 2025: Discussing the 48-month results from OAKS, DERBY and GALEByEsther Lee Kim, MD,Sydney M Crago,Sheryl StevensonOctober 19th 2025
AAO 2025: Ken Beckman discusses trial demonstrating safety and efficacy of epithelium-on CXLByKen Beckman, MD, FACS,Sydney M Crago,Sheryl StevensonOctober 18th 2025
AAO 2025: Arshad M. Khanani, MD, MA, FASRS, shares GA results from the GATHER2 extension trialByArshad M. Khanani MD, MA, FASRS ,Sheryl StevensonOctober 17th 2025